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Abstract
Rapid molecular typing of bacterial pathogens is critical for public health epidemiology, surveillance and infection
control, yet routine use of whole genome sequencing (WGS) for these purposes poses significant challenges. Here
we present SRST2, a read mapping-based tool for fast and accurate detection of genes, alleles and multi-locus
sequence types (MLST) from WGS data. Using >900 genomes from common pathogens, we show SRST2 is highly
accurate and outperforms assembly-based methods in terms of both gene detection and allele assignment. We
include validation of SRST2 within a public health laboratory, and demonstrate its use for microbial genome surveillance
in the hospital setting. In the face of rising threats of antimicrobial resistance and emerging virulence among bacterial
pathogens, SRST2 represents a powerful tool for rapidly extracting clinically useful information from raw WGS data.
Source code is available from http://katholt.github.io/srst2/.
Background
Rapid molecular typing of bacterial pathogens is critical
for public health epidemiology, surveillance and infec-
tion control [1,2]. Two key goals of such activities are:
(1) to detect the presence of genes linked to clinically
relevant phenotypes - including virulence genes, anti-
microbial resistance genes or serotype determinants; and
(2) to classify isolates into clonal groups, via multi-locus
sequence typing (MLST [3]) or detection of clone-
specific or other epidemiological markers. Whole genome
sequencing (WGS) or ‘genomic epidemiology’ is increas-
ingly being adopted for these tasks and has the potential
to replace current techniques which are mainly based on
PCR and/or restriction enzyme digestion coupled with se-
quencing or size separation via electrophoresis [1,4]. WGS
is particularly attractive as: (1) it can be applied simultan-
eously to large numbers of bacterial isolates of any species
with no need for organism- or target-specific reagents;
and (2) the resulting data are readily shareable, can be
compared easily with past and future data sets, and are in-
formative for both routine surveillance (monitoring genes
and clones) and detailed outbreak investigation (genome-
wide phylogenies for transmission analysis) [2,4].
WGS has revolutionised pathogen research, and its
potential to revolutionise the practice of public health
epidemiology, surveillance and infection control has
been recognised for some time [4-10]. Despite the en-
thusiasm and several demonstration studies [11-16], the
routine use of WGS poses significant challenges for pub-
lic health and diagnostic laboratories, foremost of which
is a lack of solutions for the rapid and reproducible ex-
traction of informative, interpretable and shareable data
from raw sequence data [1,17].
Currently available methods rely on assembling short
reads into longer contiguous sequences (contigs), which
can be interrogated using BLAST or other search algo-
rithms to identify genes or alleles of interest (for ex-
ample, ARG-Annot [18]; ResFinder, PlasmidFinder and
MLST typer [19-21]; BIGSdb [22,23]). The reliance on
assembly introduces efficiency and sensitivity problems
due to the data, time and computational requirements
for generating high quality assemblies of bacterial ge-
nomes from short reads. There are several assemblers
(for example, Velvet [24], SPAdes [25]) that can produce
a bacterial genome assembly in minutes to hours with a
few gigabytes of memory. However, the production of
high quality assemblies with these tools requires quality
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filtering and other preprocessing of reads as well as opti-
misation of kmer length and other parameters which
in practice requires several alternative assemblies to be
generated and compared [26,27], thus multiplying by an
order of magnitude the amount of computational time
and memory required to produce each genome prior
to typing analysis. Further, the quality of even highly
optimised assemblies remains highly variable, even for
closely related genomes sequenced together in multiplex.
Hence assembly-based analyses of genomes sequenced
with short-read technology are very difficult to standard-
ise and quality control, which is important to ensure ro-
bust, reliable and reproducible assays for use in public
health and infection control.
Here we describe a new tool for genomic epidemiology,
SRST2, which performs fast and accurate detection of
genes and alleles direct from WGS short sequencing reads.
SRST2 can type reads using any sequence database(s) and
can calculate combinatorial sequence types defined in
MLST-style databases [3]. We demonstrate its utility for
routine molecular typing in public health and hospital
laboratories via automated MLST and typing of virulence,
antimicrobial resistance and plasmid genes. SRST2 is
named after our earlier tool SRST (Short Read Sequencing
Typing) which performed MLST on short reads [28], how-
ever the SRST2 code is entirely novel and uses different
read mapping, scoring and reporting algorithms to SRST,
is more stable and robust, and is designed for gene detec-
tion and allele typing as well as MLST.
Implementation
Given a read set and database of reference allele se-
quences, SRST2 is designed to perform two key tasks:
(1) detect the presence of a gene or locus; and (2) deter-
mine the precise or closest matching allele for that locus,
among a set of possible reference allele sequences. The
approach is illustrated in Figure 1. A database of refer-
ence sequences must be provided in fasta format, in
which the fasta headers indicate both the locus (so that
alleles of the same locus can be compared) and a unique
name for each allele. In the case of MLST data an add-
itional database of ST profiles is provided as tab-delimited
text, which assigns STs to unique combinations of alleles.
Current MLST data (allele sequences and profile defini-
tions) can be downloaded from pubmlst.org automatically
using the getmlst.py script supplied with SRST2. For most
MLST schemes, these files are compatible with SRST2
and can be used without modification. Improperly for-
matted databases, or other private sequence databases,
can be easily formatted for use with SRST2 using the
scripts supplied with the program. Any number of se-
quence databases can be analysed in a single run, allowing
for simultaneous typing of MLST, resistance genes and
virulence genes.
For each input database, reads are aligned using bowtie2
[29] v2.1.0 or above with the ‘–very-sensitive-local’ and ‘-a’
settings, and all alignments are reported to a file in SAM
format. Mapping sensitivity can be fine-tuned by specifying
to SRST2 any of the parameters available within the bow-
tie2-align command or a maximum number of mismatches
per read (default 10 mismatches allowed). Flags in the
resulting SAM file are modified so that each read is in-
cluded in the pileup for every allele to which it is aligned.
Pileups are generated using SAMtools v0.1.18 [30] mpileup
and parsed by SRST2 to determine percent coverage, diver-
gence, and mismatches as well as to calculate a score for
each possible allele.
Allele scoring
An overview of the scoring approach is given in Figure 1.
We begin with an alignment of reads from sample s to a
reference sequence r. At each position i in the reference se-
quence r (ri), let si be the set of reads in sample s that align
to ri. Let ai be the total number of reads in si, and let bi be
the number of reads in si in which the aligned base does
not match the reference base at ri. If sample s contains the
precise sequence r, then the probability of a mismatched
base at any position in an aligned read is equal to the per-
base error rate of the sequencing technology ei, which for
Illumina is taken to be 0.01, although this can vary depend-
ing on what preprocessing steps are implemented [31,32].
To quantify the evidence against the presence of the
reference sequence r in s, we perform a Binomial test at
each position ri, to generate a one-sided P value Pi to assess
the probability of observing ai-bi successes in ai trials, with
a probability of success of 1-ei. Any change at position
ri - including a base substitution, an insertion of any size
or a deleted base - is treated as a mismatch, incrementing
bi by 1. For large deletions that result in an absence of any
aligned reads (including truncations of the end of the
sequence), ai = 0 and no binomial test is possible. In this
case, the evidence for the deletion is provided by the reads
which align adjacent to the deletion but do not align
across the deletion. Hence we calculate the average num-
ber of reads aligned to the two bases preceding the dele-
tion, di, and conduct the binomial test with ai = bi = di.
We then utilise a non-parametric approach to score
each allele by considering the set of all P values calcu-
lated for reference sequence r. First, to minimise arte-
facts associated with fluctuation in read depths, we (a)
set Pi = 1 where bi = 0, and weight Pi by the relative read
depth (that is, weight of evidence) at position ri com-
pared to those of other positions in r:
weightedPi Pi;w
  ¼ Pi  ai=rmax depth
 
We then compare the sorted -log10(Pi) values versus
those of the theoretical distribution of -log10(xj/n) where
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Figure 1 (See legend on next page.)
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n = length(r) and xj = 1,2,…n, analogous to a quantile-
quantile (QQ) plot (Figure 1). A linear model is fitted to
the two probability distributions and the resulting slope
is taken as the score for reference sequence r, scorer.
Here we leverage a common criticism of linear models
to our advantage: the susceptibility to outliers at the tails
of the distribution. In this case, outliers are typically
SNPs or indels relative to the sequence r which, because
they result in low P values in the binomial test and thus
very high values of -log10(P), are at the end of the ob-
served distribution (Figure 1). Thus when a linear model
is fitted, its slope increases with the number of well-
supported SNPs and indels compared to the reference.
As a result, among reference alleles of the same locus,
the sequence r with the lowest scorer (flattest slope in
the QQ plot) is the most likely match for sample s.
Reporting outputs
For each sample s and each locus or gene cluster, SRST2
output tables report the lowest scoring allele sequence r,
the average read depth of s across r and indicators of
any evidence against a precise match with r (including
mismatches supported by >50% of aligned reads, or read
depth falling below a cutoff ). Only matches passing the
user-set coverage and divergence cutoffs (by default, >90%
coverage and <10% divergence) are reported. For MLST
data, STs are calculated according to the MLST profiles
database provided, based on the closest matching alleles at
each locus.
Normally, an exact match between r and s would be
assigned if (a) r has the lowest scorer among the set of
alleles of the same locus or gene cluster, and (b) there
are no SNPs or indels between r and s. If (a) holds but
(b) does not, this is indicative of a novel allele and
SRST2 will flag the result in output tables. In such cases,
we recommend that users who are interested in defining
novel alleles should inspect the raw sequence data
(which may be assisted by the alignments, pileups and
consensus fastq files generated by SRST2).
Optionally, SRST2 can report the full details of scoring
s against all reference sequences r, to enable users to
parse and interpret the results to suit specific needs.
These include average depth of s across r, average depth
across the first and last two bases of r, the number of
positions in r in which the majority of aligned reads in s
show a mismatch against r (with SNPs, insertion/deletions
and truncations reported separately), the depth of bases
neighbouring truncations and, for the position with the
greatest proportion of mismatching reads, the total aligned
reads, total mismatching, proportion mismatching, and
binomial P value.
Major differences between SRST and SRST2
SRST2 is new code and takes an entirely different ap-
proach to read mapping, scoring alignments and report-
ing results than SRST [28], which was designed solely
for MLST and is unsuitable for detection of acquired
genes. In SRST, bwa was used for global alignment of
reads to MLST loci and their flanking sequences; in
SRST2, bowtie2 is used for local alignment of reads to
any locus, without need for flanking sequences, allowing
detection of acquired genes as well as MLST. SRST
scores were calculated in an entirely different way and
were not designed to take into account deletions/trunca-
tions or the relative weight of evidence provided by each
position in the alignment (differences in read depth).
SRST2 allows finer control of mapping and scoring pa-
rameters and provides more detailed reports than SRST.
SRST2 is also faster (2 to 5×) and slightly more reliable
than SRST for MLST analysis (see below).
Methods
Bacterial isolates and sequencing
A total of 231 Listeria monocytogenes isolates were ana-
lysed in this study, at the Microbiological Diagnostic Unit
(MDU) Public Health Laboratory in Victoria, Australia.
MDU is the national reference laboratory for L. monocyto-
genes and the isolates analysed include several from recent
outbreaks as well as from the laboratory’s reference col-
lection. Ethical approval was not required for the use of
reference laboratory isolates in this project. Cultures of
L. monocytogenes isolated from food, environmental or
(See figure on previous page.)
Figure 1 Summary of SRST2 approach. Inputs are reads (fastq format) and one or more databases of reference allele sequences for typing
(fasta format). Reads are aligned to all reference sequences (using bowtie2) and each alignment processed (using SAMtools). At each position in
each alignment, the number of matching and mismatching bases is determined and a binomial test is performed to assess the evidence against
the reference allele; resulting in a set of P values for each reference allele sequence. To determine which of all known reference alleles is most
likely present at a given locus, the P value distributions for known alleles are compared as described in the text. Briefly, for each allele the P values
expected if the reads were derived from the reference allele in the presence of a given level of sequencing error (set to 1% of bases by default) are
regressed on those actually observed, similar to a Q-Q plot; the slope of the fitted line, which increases with the strength of evidence against the
reference allele, is calculated and taken as the score for that allele. The scores file (optional output) contains the scores for each allele at each locus,
along with additional information about the alignments for each allele including percent coverage. For each locus, the allele with the lowest score
is accepted as the closest matching allele (small arrows) and reported in the output table. In MLST mode, sequence type (ST) definitions are
provided as input and used by SRST2 to calculate STs for each read set.
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clinical specimens were purified by two successive
single colony selections after streaking onto horse blood
agar (HBA) incubated for 18 to 24 h at 37°C. Resultant
bacterial growth on the surface of HBA medium was asep-
tically collected and resuspended in a cryotube (Nalgene)
containing 1 mL of sterile glycerol storage broth (1.6% w/v
Tryptone, Oxoid Pty Ltd, LP0042 containing 20% v/v
glycerol) prior to storage at -70°C. Cultures were retrieved
from storage as required and freshly grown (HBA, 18 to
24 h at 37°C) in preparation for DNA extraction. DNA
was extracted from each isolate using QIAmp DNA Mini
Kit (Qiagen) and eluted in EB buffer (Qiagen) (Tris buffer,
no EDTA).
DNA samples were subjected to traditional L. monocy-
togenes MLST analysis [33,34], with a minor modifica-
tion to the annealing temperature for the bglA PCR
(52°C not 45°C). The PCR products were purified with
FastAP Thermosensitive Alkaline Phosphatase (Thermo
Scientific) and Exonuclease I (Thermo Scientific). The
purified PCR products were sequenced using BigDye
Terminator v3 chemistry followed by capillary sequencing
using a 3130xL Genetic Analyzer (Applied Biosystems).
Trace analysis was conducted using BioNumerics version
6.6 with MLST Online plugin version 2.13 and Batch
Sequence Assembly plugin version 1.34.
DNA was subjected to multiplex library preparation
using Nextera XT followed by sequencing using an
Illumina MiSeq. DNA was quantified by Qubit dsDNA
HS Assay Kit (Invitrogen) and normalised to 0.2 ng/μL.
Total 1 ng of DNA was used for Nextera XT DNA Sample
Preparation Kit (Illumina). Tagmentation of genomic
DNA, PCR amplification with dual index primers,
PCR clean-up using Agencourt AMPure XP (Beckman
Coulter), DNA libraries normalization, library pooling
and MiSeq sample loading were performed according to
the manufacturer’s instruction with minor modifications.
For longer than 2 × 250 bp runs on the MiSeq, 25 μL of
AMPure XP beads was added to each PCR-amplified
product during the PCR purification step otherwise
30 μL of AMPure XP beads was added. For some sam-
ples, after PCR purification, DNA fragment size and
library concentration was analysed by 2100 Bioanalyzer
(Agilent Technologies) and Qubit dsDNA HS Assay Kit
(Invitrogen). DNA libraries were normalized manually to
4 nM and libraries with unique indexes were pooled in
equal volumes. Each resulting pooled library was dena-
tured and diluted with 0.2 N NaOH and pre-chilled HT1
(Illumina) to produce a 20 pM denatured library in
1 mM NaOH. Prior to the MiSeq run, the denatured
library was further diluted with pre-chilled HT1 to
approximately 12 to 13.5 pM. A total of 600 μL of
library including 2% (v/v) 20 pM denatured PhiX library
(Illumina) was loaded together with MiSeq reagent kit v3
(Illumina) according to the manufacturer’s instructions.
Publicly available short read data used in this study
Details of Illumina read sets used in this study are pro-
vided in Table 1 and Table 2. Data tables specifying the
expected STs of each read set, summarised from pub-
lished papers, are given in Additional file 1 [35].
Subsampling of read sets
To explore accuracy at low read depths, 10 genomes
each of S. aureus and E. faecium were selected for
random subsampling of reads to simulate genomes
sequenced to low read depth. To do this, we used the
mean read depth across MLST loci to calculate the
sampling fraction required to achieve approximately
1×, 2×, … 10× mean read depth. We randomly sampled
reads from the forward reads file at the required sampling
fraction, and extracted the corresponding reverse reads,
using Perl scripts. Ten random samples were generated
from each read set at each depth level, generating a total of
1,000 read sets for each species.
Sequence databases used in this study
MLST databases for Staphylococcus aureus, Streptococcus
pneumoniae, Salmonella enterica, Escherichia coli, Entero-
coccus faecium, Listeria monocytogenes and Enterobacter
cloaceae were downloaded from pubmlst.org using the
getmlst.py script included with SRST2 (June 2014).
Antimicrobial resistance gene detection was performed
using the ARG-Annot database of acquired resistance
genes [18]. Allele sequences (DNA) were downloaded in
fasta format [43] (May, 2014). Sequences were clustered
into gene groups with ≥80% identity using CD-hit [44]
and the headers formatted for use with SRST2 using the
scripts provided (cdhit_to_csv.py, csv_to_gene_db.py). A
copy of the formatted sequence database used in this
study is included in the SRST2 github repository [35].
Representative sequences for 18 plasmid replicons
were extracted from GenBank using the accessions and
primer sequences specified by Carattoli et al. [45]. A
copy of the formatted sequence database used in this
study is included in the SRST2 github repository [35].
Simulation of expanded S. aureus MLST database
As more genomes are sequenced and as bacteria con-
tinue to evolve, novel alleles will continue to be discov-
ered and thus the size of allele databases will increase.
To explore the impact of database size on accuracy of
allele detection with SRST2, we simulated expansion of
the current S. aureus MLST database from 2,161 alleles
(mean 309 per locus) to 5,578 alleles (mean 797 per
locus). The additional 500 alleles (approximately) per
locus were generated using netrecodon v6.0.0 [46]. Se-
quences derived from the true MLST database were
used to seed the simulation at each locus as follows.
Existing alleles were translation-aligned between start
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(alignment start) and stop (alignment end) codons, those
containing a frameshift or stop codon were removed,
and the modal consensus sequence was exported. The
best-fit DNA substitution model of each true alignment
was determined using the AIC in MrModeltest v2.3, as
implemented in PAUP* v4.0b. In netrecodon, the modal
sequences were forward evolved under the coalescent,
using the parameters of the best-fitting model for each
locus, mutation rate 1E-7 and recombination rate 1E-7/
15 (based on reported r/m of 1/15 [47]). A total of 100
independent replicates of forward evolution were per-
formed per locus, retaining 2,000 sequences per replicate
(N = 200,000 simulated sequences per locus). The first
500 unique simulated sequences at each locus were
added to the MLST database, and duplicate sequences
were removed.
Assembly-based analysis
Assemblies were generated using the de novo assembler
Velvet v1.2.10 [24], with optimal kmer choice for each
read set refined through iterative calls to VelvetOptimiser
v2.2.5 [48]. Briefly, each read set was assembled using a call
to VelvetOptimiser with kmers from 29 up to 89, in steps
of 12. The optimal kmer, k1, was extracted and a second
call to VelvetOptimiser was made using kmers from k1-12
up to k1 + 12, in steps of 4. A final call to VelvetOptimiser
was run using kmers from k2-4 up to k2 + 4, in steps of 2.
The final assembly was that output from the third and final
call to VelvetOptimiser.
For MLST analysis from assemblies, a nucleotide
BLAST + (v2.2.25) search was performed for each locus
and each contig set. In this BLAST search, the contig set
was used to query the database containing all known
allele sequences for a given locus, and the top BLAST
hit was reported. If this hit had ≥90% nucleotide identity
across ≥90% of the length of the reference allele se-
quence, an allele call was recorded. If the hit was an
exact match to a known allele (that is, 100% nucleotide
identity across 100% of the length of the allele sequence),
this was considered a precise allele call. The Python code
used is available within the SRST2 distribution. Where the
hit was not an exact match (n = 42), an alternative nucleo-
tide BLAST analysis was performed using the allele se-
quences as query and the contig set as database, and the
results manually inspected to determine whether it was
possible to identify the correct allele from the assembly.
For gene detection analysis from assemblies, a nucleotide
BLAST search was performed in which the set of reference
sequences (sequence database, that is antimicrobial resist-
ance gene database) was used to query the database of all
contigs for that assembly.
SRST (v1) analysis
The 543 read sets used for validation of SRST2 allele
calling (Table 1) were also analysed using SRST [28], run
with default settings.
Web-based analysis with MLST Typer and ResFinder
The 44 S. enterica read sets (Table 1) were analysed
using the MLST Typer [21] and ResFinder [19] websites.
This data set was chosen to begin with as it is the smal-
lest of those used for validation in the manuscript (n = 44).
Each read set took 3 to 4 h to upload and analyse using
these websites, and had to be done in serial as attempting
Table 1 Data sets used to assess accuracy of SRST2
Species Citation N (isolates) Population Sequencing centre Average read
depth
Read length (bp)
Staphylococcus aureus [36] 134 Clonal, ST22 Sanger, UK 24× 55
Staphylococcus aureus [37] 128 Clonal, ST239 Sanger, UK 60× 65
Streptococcus pneumoniae [38] 113 Clonal, ST81 Sanger, UK 30× 55
Salmonella enterica Typhimurium [39] 44 Clonal, ST313 Sanger, UK 34× 76
Shigella (E. coli) [40] 81 Clonal, S. sonnei Sanger, UK 25× 55
Enterococcus faecium [41] 43 Diverse, dominated
by ST203, ST17
Melbourne, Australia 658× 101
Listeria monocytogenes This paper 231 Diverse Melbourne, Australia 36× 152
Table 2 Data sets used to demonstrate utility of SRST2 in the hospital setting
Species Citation N (isolates) Average read depth Read length (bp)
Enterococcus faecium (Figure 7a-c) [41] 43 658× 101
Hospital outbreak investigations (Figure 8a-b) [15] 20 36× 151
K. pneumoniae, E. coli [42] 69, 74 34× 101
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to run multiple jobs crashed Java. Therefore it was not
feasible to test all read sets for comparison.
MLST Typer was run using default settings and the
Salmonella enterica MLST database. ResFinder cutoffs
were set to >90% identity, >80% coverage (no >90% cut-
off was available), and ‘all’ AMR loci. To facilitate direct
comparison with ResFinder, the S. enterica read sets
were re-analysed with SRST2 using the ResFinder resist-
ance gene sequence database downloaded from the
ResFinder website (a copy of the SRST2-formatted
ResFinder database is provided in the SRST2 distribution,
along with the ARG-Annot resistance gene database
which we recommend). All S. enterica Typhimurium carry
a chromosomally encoded copy of aac(6’)-Iaa, which is
included in the ResFinder and ARG-Annot databases as it
can occur as an acquired resistance gene in other organ-
isms. Hence this provides a ‘gold standard’ estimate of
gene detection and is reported separately to the acquired
resistance genes for which no independent confirmation
of gene presence/absence is available (Table 3).
Analysis runs and time calculations
All SRST2, SRST, assembly and BLAST analysis was run
on a Linux cluster (iDataplex × 86 system, ‘Barcoo’ clus-
ter at VLSCI [49]). SRST2 was run with default parame-
ters. Details of Velvet assembly and BLAST analysis are
given below. Run times were calculated from time stamps
extracted from log files for SRST2 and Velvet Optimiser
assembly runs.
Statistical analysis
All statistical analysis and data plotting was per-
formed in R. Allele calling performance of SRST2 and
assembly + BLAST was assessed via three metrics: (1) call
rate = total number of allele calls made, for SRST2 this
was a call with ≥90% coverage and no uncertainty re-
corded (that is, with ≥2× read depth at both ends and
also neighbouring any truncations or deleted bases), for
BLAST this was a call with ≥90% coverage and ≥90% nu-
cleotide identity; (2) false positive rate = total number of
correct allele calls as a proportion of all calls; and (3) pro-
portion of all tests resulting in a call with a correct allele,
equal to (call rate) * (1 - (false positive rate)). As these
metrics are proportions, the significance of differences in
performance metrics was calculated using a two-sided
test for equality of proportions (prop.test function in R).
Resistance gene detection was assessed using a cutoff
Table 3 Comparison of SRST2 and ResFinder (ref 19) for
detection of acquired resistance genes
Correct calls N (%)
Aac(6’)-Iaa (chromosomally encoded core gene, expect in all strains)
Both methods 35 (83%)
SRST2 only 7 (17%)
ResFinder only 0
Acquired resistance genes (total 44 detected)
Both methods 24 (55%)
SRST2 only 20 (45%)
ResFinder only 0
42 S. enterica serovar Typhimurium read sets (accessions in Table 1) with >1×
mean read depth were analysed using the ResFinder website, and also with
SRST2 using the sequence database downloaded from the ResFinder website.
Results are shown separately for the chromosomally encoded core resistance
gene aac(6’)-Iaa, which is expected to be in all strains, and horizontally
acquired resistance genes.
Figure 2 Run times for MLST analysis with SRST2. Lines are linear regression of runtime on reads, calculated separately for each species from
public data sets (details in Table 1).
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of ≥90% coverage and ≥90% identity to define the presence
of a gene.
Results and discussion
Validation of allele calling
To assess the accuracy of allele identification with
SRST2, we analysed publicly available Illumina data from
543 bacterial genomes of five different species for which
independent MLST data were available (Table 1). With
seven loci in each MLST scheme, this yielded 3,801 allele
calls across 35 loci to assess call rate and false positive
rate. The read sets represented a wide range of average
read depths, with 90% in the range 12× - 130× and 50%
between 20× - 60× (Table 1). For each species, we used
SRST2 to download the latest MLST database from
pubmlst.org and subsequently ran SRST2 using default
parameters. Median run time was 6 min per sample
(interquartile range, 4 to 10 min) and increased linearly
with number of reads (Figure 2). Efficiency can be easily
improved or standardised, without data preprocessing,
by instructing SRST2 to map the first N reads only.
SRST2 call rates and true positive rates increased with
average read depth, stabilizing with depths ≥15× (Figure 3a,
Additional file 2). For comparison, we also assembled
Figure 3 Overall accuracy of SRST2 allele calling and gene detection. (a) MLST analysis of public data from five species (N = 543 genomes,
3,801 loci, details Additional file 1: Table S1). Tests were grouped by read depth and accuracy rates (left y-axis, correct allele calls as a proportion
of tests), calculated at each depth (x-axis, red slashes indicate scale change). Grey bars, number of tests at each depth (right y-axis); Lines, accuracy
of allele calling. (b) MLST analysis of Listeria monocytogenes data (N = 231 genomes, 1,671 loci) conducted in a public health laboratory; colours
and axes as in (a). (c) Accuracy of vanB resistance gene detection for E. faecium read sets subsampled to low depth; y-axis shows proportion of
correct (presence vs. absence) calls as a proportion of 100 tests at each depth; colours and axes as in (a). A call of ‘present’ implies detection
of ≥90% of the length of the gene at ≥90% nucleotide identity.
Table 4 Comparison of SRST2 and SRST (v1, ref 28)
Correct calls N (%)
Both 491 (90.4%)
Neither 18 (3.3%)
SRST2 only 21 (4%)
SRST (v1) only 13 (2.4%)
Summary of correctly called MLST sequence types (STs) for 543 bacterial
isolates from five species (data set detailed in Table 1).
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each read set using Velvet [24] and VelvetOptimiser
[48] and used nucleotide BLAST to identify MLST
alleles (assembly + BLAST method; Methods). At read
depths ≥15×, SRST2 made significantly more allele calls
than assembly + BLAST (call rates 99.9% vs. 95.9%, re-
spectively; P <1 × 10-15), with equivalent accuracy (0.46%
vs. 0.22% of allele calls incorrect; P = 0.16). The heuristic
information provided by SRST2 (that is, confident mis-
matches, insertions, deletions or truncations reported
from read mapping) was a strong indicator of accuracy in
the result: where an exact match was reported (98% of
calls with depth ≥15×), 0.2% of allele calls were incorrect;
where an inexact match was reported, 11.7% of allele
calls were incorrect. Hence, the key difference between
the two methods was the ability of SRST2 to make cor-
rect calls where assembly + BLAST could not make any
call: for read depths ≥15×, SRST2 made a call with
the correct allele 99.4% of the time, compared to only
95.7% for assembly analysis (P <1 × 10-15 for difference in
frequencies of correct allele calls). At sequence type (ST)
level, the difference was even greater: SRST2 achieved ac-
curate ST assignment for 98% of isolates with average
depth ≥15×, whereas assembly + BLAST correctly identi-
fied only 79%. SRST2 also performed better than SRST
and the MLST typer website (which implements an alter-
native assembly + blast approach), see Tables 4 and 5.
To assess performance at low read depths (≤15×), 10
S. aureus read sets were subsampled to low depths
(Methods). This confirmed that an average depth of only
10× was required for SRST2 to achieve >90% call rate
and <0.5% false positives (Figure 3a, Figure 4). MLST
databases can be expected to grow indefinitely due to
increasing diversity and broader sampling. However sim-
ulations (Methods) indicated that doubling the size of
the S. aureus MLST database had no impact on SRST2
accuracy (Figure 3a, Figure 4).
Validation of gene detection using the vanA-B
resistance gene
In addition to reliably distinguishing alleles of a given
gene, SRST2 can also accurately determine the presence
or absence of genes of interest, such as those encoding
antimicrobial resistance or virulence. To evaluate this,
we used 43 E. faecium genomes (Table 1), previously
screened for vancomycin susceptibility and presence of
the VanB vancomycin resistance operon vanABHSXY
[41,50]. Seventeen isolates were vancomycin resistant
(VRE), and all were PCR positive for the vanA-B gene.
These genomes were sequenced to approximately 1,000×
depth and SRST2 correctly detected vanA-B in 17/17
Figure 4 Accuracy of SRST2 allele calling at low read depths and with expanded MLST database size. MLST analysis of public S. aureus
data. (N = 10 read sets; each sampled 100 times to different depths; details in Methods). Tests were grouped by read depth and accuracy rates
(y-axis, correct allele calls as a proportion of all tests), calculated at each depth (x-axis, red slashes indicate scale change from 1× to 10×). Red,
real S. aureus MLST database; blue, expanded S. aureus MLST database (see Methods); grey, unsampled data from five species mapped to real
databases (as shown in Figures 1 and 3).
Table 5 Comparison of SRST2 and MLST Typer (ref 21)
Correct calls N (%)
Both 14 (33%)
Neither 1 (2%)a
SRST2 only 27 (61%)
MLST Typer only 0
Summary of correctly called MLST sequence types (STs) for 42 S. enterica
serovar Typhimurium read sets (accessions in Table 1) with >1× mean
read depth.
aERR023807 had 44× read depth and was not called by MLST Typer, but six/seven
alleles were correctly called by SRST2.
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VRE. In five vancomycin sensitive (VSE) isolates PCR
negative for vanA-B, SRST2 detected VanA-B sequences
at very low depths (<0.2% of average depth), probably
caused by minor but easily identifiable contamination
during VRE-VSE multiplexed sequencing. SRST2 also
confirmed the presence of the entire VanB operon,
which is strongly predictive of the VRE phenotype.
For comparison, assembly + BLAST identified full-length
vanA-B sequences in just 7/17 VRE genomes, with mul-
tiple smaller hits spanning the full-length gene in five
VRE and <50% coverage of the gene identified in the
remaining five VRE. To investigate the effect of sequen-
cing depth on gene detection, we randomly selected five
VRE and five VSE read sets for subsampling at <10×
average read depth. VanA-B was only ever detected in
confirmed VRE genomes, and sensitivity of detection with
SRST2 reached 100% for read sets with ≥5× average read
depth (Figure 3c).
To further explore the relative sensitivity of gene de-
tection with SRST2, we screened all the read sets used
for MLST validation (Table 1) for antimicrobial resist-
ance genes in the ARG-Annot database of acquired resist-
ance genes [18] (Methods). SRST2’s detection of whole
genes was more sensitive than detection of whole or
partial gene sequences by assembly + BLAST (Figure 5):
6.8% of genes detected at ≥90% coverage by SRST2 at
depths ≥15× were not found at ≥90% coverage in as-
semblies. For most of these genes, smaller fragments
were detected by BLAST (Figure 5); however, SRST2
has the advantage of sensitive detection and confident
Figure 5 Resistance gene detection. (a) Venn diagram of antimicrobial resistance genes detected by SRST2 and assembly + BLAST, where the
threshold for ‘detection’ of a gene is ≥90% coverage and ≥90% identity with a reference allele. No genes were detected by assembly + BLAST but
not SRST2. (b) Distribution of average read depths per gene, calculated by SRST2 from mapped reads, for all genes detected by SRST2. (c) Coverage
and nucleotide identity (%ID), as calculated by SRST2, for all genes detected by SRST2 but not by assembly + BLAST. (d) Impact of lowering the
coverage threshold for detection of genes by BLAST (for those genes with ≥15× read depth).
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allele-calling across the full length of genes, even at
low depths (Figures 3c and 5). SRST2 also performed
substantially better than the ResFinder website, which
implements an alternative assembly + blast approach
(Table 3).
Validation of SRST2 in a public health laboratory
To validate SRST2 in a public health laboratory setting,
we analysed 231 clinical isolates of Listeria monocyto-
genes and compared MLST data obtained from gold-
standard PCR and amplicon sequencing with those
obtained from SRST2 or assembly + BLAST analysis
of Illumina MiSeq data (Figure 3b). Sequencing and ana-
lysis were performed by the Microbiological Diagnostic
Unit Public Health Laboratory in Melbourne, Australia,
the national reference laboratory for L. monocytogenes. For
average read depths ≥15×, SRST2 had a substantially
higher call rate than assembly-based analysis (99.6% vs.
95.7%; P <1 × 10-12), with similar low false positive rates
(0.7% vs. 0.6%; P = 0.9). Hence, for samples with ≥15× data,
a total of 99% of all alleles were called correctly by SRST2,
a significantly higher proportion than the 95% achieved
by assembly + BLAST (P <1 × 10-12). At <15× read depths,
SRST2 also performed better than assembly-based analysis
(87% vs. 72% of alleles correctly called, respectively,
P <1 × 10-3; Figure 3b).
Further, SRST2 is already being assessed for routine
MLST analysis of Streptococcus pneumoniae at Public
Health England (Anthony Underwood, personal commu-
nication), and the open-source SRST2 code has been
adapted by Public Health Ontario, Canada to perform
specialist emm typing of Group A Streptococcus [51].
Figure 6 SRST2 analysis of sequence types and beta-lactamase CTX-M-15 genes among hospital isolates. Rates of isolation of different
sequence types (STs), coloured by CTX-M-15 status, as determined by SRST2 run with default parameters on a public data set of strains from a
single hospital. In each species, a single known ST dominates the population (highlighted) and is also the dominant source CTX-M-15 genes.
‘*’ next to an ST indicates a match to the closest defined ST; that is, that for all seven loci the closest known allele is the one belonging to
that ST, however at ≥1 these loci there is an imprecise match (SNP or indel) compared to the known allele sequence. ‘Novel’ indicates a novel
sequence type resulting from a combination of known alleles, with precise matches at all loci (‘NF’ in SRST2 output); ‘Novel*’ indicates a novel
combination of alleles, with ≥1 of those alleles being novel itself (that is, with no exact match in the MLST database) (‘NF*’ in SRST2 output).
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Figure 7 SRST2 analysis of E. faecium hospital data and hospital outbreak investigation. Temporal distribution of isolates is shown in
(a) coloured by vancomycin resistance as inferred from vanA-B detection with SRST2, and in (b) by coloured by sequence type inferred by SRST2.
(c) Summary of all SRST2 results by sequence type (ST), in order from left to right: single linkage clustering of STs by number of shared alleles;
MLST allele profiles; heatmap indicating the proportion of isolates that carries each resistance gene (scale as indicated), frequency of the ST (axis as
indicated, coloured as in (b)).
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Identification of antimicrobial resistant clones
In a hospital setting, the combination of MLST and gene
detection can provide rapid and powerful insights for in-
fection control without specialist bioinformatics know-
ledge. SRST2 analysis of 69 K. pneumoniae and 74 E. coli
genomes from a UK hospital [42] revealed that each
was dominated by a single ST with a high rate of the
extended-spectrum beta-lactamase (ESBL) gene CTX-
M-15 (K. pneumoniae ST490 comprising 25% of total,
71% of ESBL; E. coli ST131 comprising 40% of total, 77%
of ESBL; Figure 6). Routine SRST2 surveillance of ESBL
infections could be indicative of hospital outbreaks and
used to identify which isolates should be investigated via
transmission analysis.
Using the E. faecium genome data, collected as part of
a 12-year hospital study of vancomycin resistance [41],
SRST2 took approximately 30 min to generate the results
and visualisations shown in Figure 7, indicating: (1)
Figure 8 SRST2 analysis of hospital outbreak investigation. (a) Isolate genetic profiles obtained from SRST2 analysis, indicating that case EF4
was distinct in both sequence type and resistance gene profile from the outbreak cases EF2 and EF3. Full WGS analysis showed a similar result
[15]. (b) Isolate genetic profiles obtained from SRST2 analysis, including plasmid replicons detected (pink). The profiles indicate that case EC3
shared the same sequence type as the linked cases EC1 and EC2 (ST94), but lacked the IncA/C plasmid and had a distinct resistance gene profile.
Full WGS analysis showed that EC1 and EC2 isolates were much closer to each other (≤22 SNPs) than to EC3 (>150 SNPs) [15].
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increasing vancomycin resistance over time; (2) a shift in
dominant ST during the same period; and importantly (3)
that this was not attributable to the introduction nor
transmission of a new resistant clone, as the resistance
rates were steady (approximately 50%) across all dominant
STs. Similar conclusions typically require many days of
labour and specialised assays in the diagnostic laboratory
[52] and have been confirmed by detailed WGS analysis
showing frequent acquisition of VanB transposons by
diverse circulating strains [41].
Investigation of outbreaks and carbapenem resistance
mechanisms
We next applied SRST2 to analyse data from real-world
small-scale infection control investigations [15]. SRST2
took 5 min to generate results for suspected outbreaks
of VRE and E. cloaceae (Figure 8), in which suspected
outbreak isolates were readily distinguishable from epi-
demiologically unrelated isolates, consistent with WGS
phylogenies and manual analysis of antimicrobial resist-
ance markers [15]. SRST2 typing of 18 plasmid replicons
[45] also indicated specific plasmid replicons (IncHI2,
IncA/C) associated with two of the resistance profiles.
The authors also reported use of a complex hybrid of
assembly, mapping and manual inspection to deter-
mine carbapenem resistance mechanisms in five Gram-
negative bacteria isolated in close proximity [15]. SRST2
analysis of these five read sets identified the acquired beta-
lactamases OXA-23 in AB223; IMP, SHV-12 and TEM-1
in EC1a; CTX-M-15 and TEM-1 in Eco216; CTX-M-15
and SHV-133 in KP652; and no acquired carbapenemase
genes in EC302. These results are consistent with those
reported from manual analysis [15].
Conclusions
Rapid and reliable extraction of clinically relevant genomic
information will be essential for the adoption of WGS for
infection control and public health surveillance. SRST2
was designed specifically to generate clinically informative
genomic profiles of bacterial pathogens - encompassing
sequence type, antibiotic resistance genes and virulence
genes - direct from raw sequence data. It out-performs al-
ternative approaches, including assembly-based approaches
and our earlier mapping-based MLST software SRST, in
terms of both speed and accuracy. Here we have validated
the use of SRST2 for MLST of L. monocytogenes in a public
health laboratory, and demonstrated its utility in the hos-
pital setting for both infection control investigations and
the identification of antibiotic resistance mechanisms.
Availability and requirements
Project name: SRST2
Project home page: http://katholt.github.io/srst2/
Operating system(s): Platform independent
Programming language: Python
Other requirements: Python 2.7.5 or higher, Bowtie2
v2.1.0 or higher, and SAMtools 0.1.18.
License: BSD
Any restrictions to use by non-academics: None
Additional files
Additional file 1: A CSV table listing the 543 read file accessions
from these data sets together with the corresponding expected
sequence types (STs), which were extracted from published results
of PCR and capillary sequencing and used to assess accuracy of
SRST2 allele calling (shown in Figure 3a).
Additional file 2: Separate plots for call rates and true positive
rates for the six public data sets used for MLST allele typing
validation (these two measures were combined to give the overall
accuracy plot in Figure 3).
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